Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD (COPD-SAFE)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-31

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the safety and efficacy of high tidal volumes generated by "Adapted Support Ventilation (ASV) mode' in mechanically ventilated severe COPD patients. Every patient will be ventilated consecutively with ASV and Volume Control (VC) modes at 2 different levels of minute volume in 2 sets. ASV mode is expected to be safe measured by adequate inspiratory transpulmonary pressures and expected to be as effective as VC mode with lower intrinsic positive end expiratory pressure (iPEEP) levels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intellivent ASV in Chronic Obstructive Pulmonary Disease Patients in the ICU

NCT02651935

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Closed Loop Ventilation in Patients With COVID-19

NCT04873336

Covid19 ARDS

COMPLETED

Non-invasive Mechanical Ventilation as a Rescue Therapy to Relieve Dyspnea in Patients With Stable Severe COPD

NCT02012101

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Adaptive Non-invasive Ventilation to Abolish Tidal Flow Limitation

NCT04497090

Pulmonary Disease, Chronic Obstructive Hypercapnia Ventilator Lung

COMPLETED NA

Home Non Invasive Ventilation for COPD Patients

NCT03221101

Chronic Obstructive Pulmonary Disease Hypercapnic Respiratory Failure

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD) may require mechanical ventilation. Various mechanical ventilation strategies and modes can be used to manage respiratory insufficiency in such patients. High tidal volumes required for mechanical ventilation of patients with obstructive pathologies is a well-known fact. Adapted Support Ventilation (ASV) is an intelligent closed-loop mechanical ventilation mode which automatically adjusts ventilation to lung mechanics. Led by measured lung mechanics, ASV mode often generates higher than usual tidal volumes during mechanical ventilation of COPD patients, particularly if the minute volume (MV) target is high. Thus, the effects of high tidal volumes on inspiratory transpulmonary pressure (Ptp), and whether Ptp stays within safe limits during ASV mode is of great interest.

Patients with acute exacerbation of COPD who required mechanical ventilation will be enrolled in the first 24 hours of admission to the intensive care unit. All patients will be deeply sedated. An esophageal balloon catheter will be inserted in order to measure transpulmonary pressure. 100 % minute volume target will be calculated in advance as 100 ml per ideal body weight.

Patients will be ventilated with two different MV targets in two sets. 'Adapted support ventilation' and 'volume control (VC)' modes will be used consecutively within each set. While the target minute volume will be 100 % in the first set, the volume target in the second set will be tuned to decrease patients PaCO2 below 45 mmHg. The sequence of ventilation mode will be randomized within each set. Ventilation periods will be 30 minutes with 15 minutes washout period in between. İf Ptp increase above 20 cmH20 at any ventilation mode, the tidal volume will be decreased.

ASV mode is expected to be safe, assessed by adequate inspiratory transpulmonary pressures, and expected to be as effective as VC mode with lower intrinsic positive end expiratory pressure (iPEEP) levels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Patients will be ventilated for two different minute volume targets in two sets. 'Adapted support ventilation' and 'volume control (VC)' modes will be used consecutively in each set. Every patient will be ventilated 1.1. ASV with minute volume target of % 100; 1.2. VC with same MV target; 2.1 ASV with MV target associated with PaCo2 less than 45 mmHg; 2.2 VC with same MV target. Sequence of ventilation modes wıll be randomized within each group.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Patients will not be aware of the procedure or ventilation modes that will be performed. Outcomes will be analyzed by an independent statistician.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1.1. ASV, MV target 100%

Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.

Group Type EXPERIMENTAL

Minute volume target of 100%

Intervention Type OTHER

Patients will be ventilated to reach minute volume target of %100 (100 ml per ideal body weight).

1.2. Volume control, MV target %100

Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3 Ventilation frequency will be adjusted to reach the same volume target calculated in arm1.

Group Type ACTIVE_COMPARATOR

Minute volume target of 100%

Intervention Type OTHER

Patients will be ventilated to reach minute volume target of %100 (100 ml per ideal body weight).

2.1. ASV, MV target to reach PaCO2< 45 mmHg

Patients will be ventilated with ASV mode. Tidal volume, ventilation frequency, inspiratory duration will be automatically adjusted by the mechanical ventilator.

Group Type EXPERIMENTAL

Minute volume target to reach PaCO2 less than 45% (high tidal volume)

Intervention Type OTHER

Patients will be ventilated to reach minute volume target associated with PaCO2 less than 45%.

2.2. Volume control, MV target to reach PaCO2< 45 mmHg

Patients will be ventilated with volume control mode. A tidal volume of 6-8 ml/kg will be used. I:E ratio will be set as 1:3. Ventilation frequency will be adjusted to reach the target PaCO2 level

Group Type ACTIVE_COMPARATOR

Minute volume target to reach PaCO2 less than 45% (high tidal volume)

Intervention Type OTHER

Patients will be ventilated to reach minute volume target associated with PaCO2 less than 45%.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Minute volume target of 100%

Patients will be ventilated to reach minute volume target of %100 (100 ml per ideal body weight).

Intervention Type OTHER

Minute volume target to reach PaCO2 less than 45% (high tidal volume)

Patients will be ventilated to reach minute volume target associated with PaCO2 less than 45%.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute exacerbation of Chronic Obstructive Lung Disease
* Being intubated for less than 24 hours
* Not being planned to be extubated in 24 hours
* Expiratory time constant (RCexp) more than \> 2.0 s